Advertisement
UK markets closed

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.84
    -0.52 (-0.62%)
     

  • GOLD FUTURES

    2,328.90
    -13.20 (-0.56%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,456.18
    -1,751.66 (-3.29%)
     

  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BUZZ-GW Pharmaceuticals: Positive results from late-stage trial

Reuters - UK Focus

** Drug developer GW Pharmaceuticals (LSE: GWP.L - news) ' shares up 22.8 pct, best day in 3 mths and at 9 mth highs, after saying a late-stage trial of its epilepsy drug met its main goal

** Co says its experimental drug Epidiolex reduced the occurence of drop-seizures in patients with Lennox-Gastault syndrome

** Shares (Berlin: DI6.BE - news) among top gainers on London's AIM exchange

** Co's U.S (Other OTC: UBGXF - news) .-listed shares up 16 pct premarket, second-largest Nasdaq (NasdaqGS: NDAQ - news) -listed gainers (venkateshasoumithri.mamidipudi.thomsonreuters.com@reuters.net)